ArTS Archivio della ricerca di Trieste

ALESSIO, ENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.934
EU - Europa 13.601
AS - Asia 10.200
SA - Sud America 1.295
Continente sconosciuto - Info sul continente non disponibili 874
AF - Africa 252
OC - Oceania 26
Totale 51.182
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.586
SG - Singapore 3.663
DE - Germania 2.882
CN - Cina 2.478
IT - Italia 1.966
SE - Svezia 1.792
UA - Ucraina 1.600
RU - Federazione Russa 1.084
GB - Regno Unito 1.016
BR - Brasile 995
HK - Hong Kong 957
VN - Vietnam 927
PL - Polonia 842
KR - Corea 685
FI - Finlandia 659
FR - Francia 600
TR - Turchia 567
IE - Irlanda 298
BG - Bulgaria 295
IN - India 218
BD - Bangladesh 213
CA - Canada 183
NL - Olanda 154
AR - Argentina 117
CH - Svizzera 86
ES - Italia 72
MX - Messico 71
ID - Indonesia 56
IQ - Iraq 55
JP - Giappone 55
ZA - Sudafrica 50
SA - Arabia Saudita 49
EC - Ecuador 48
BE - Belgio 40
SN - Senegal 40
AT - Austria 36
EG - Egitto 36
CO - Colombia 35
MA - Marocco 35
CL - Cile 33
PH - Filippine 33
PK - Pakistan 28
EU - Europa 26
KE - Kenya 25
VE - Venezuela 25
RO - Romania 23
GR - Grecia 22
CZ - Repubblica Ceca 21
PT - Portogallo 21
CI - Costa d'Avorio 20
TH - Thailandia 20
AU - Australia 18
JO - Giordania 18
UZ - Uzbekistan 18
JM - Giamaica 17
RS - Serbia 17
PY - Paraguay 16
TW - Taiwan 16
AZ - Azerbaigian 14
CR - Costa Rica 13
AE - Emirati Arabi Uniti 12
LT - Lituania 12
MY - Malesia 12
DZ - Algeria 11
GE - Georgia 11
IL - Israele 11
IR - Iran 11
KZ - Kazakistan 11
NP - Nepal 11
TN - Tunisia 10
UY - Uruguay 10
BA - Bosnia-Erzegovina 9
TT - Trinidad e Tobago 9
GT - Guatemala 8
HU - Ungheria 8
PA - Panama 8
SV - El Salvador 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
HR - Croazia 7
NZ - Nuova Zelanda 7
OM - Oman 7
PE - Perù 7
KG - Kirghizistan 6
KW - Kuwait 6
SK - Slovacchia (Repubblica Slovacca) 6
BY - Bielorussia 5
HN - Honduras 5
LV - Lettonia 5
PS - Palestinian Territory 5
AL - Albania 4
BH - Bahrain 4
DK - Danimarca 4
EE - Estonia 4
LB - Libano 4
LK - Sri Lanka 4
NG - Nigeria 4
PR - Porto Rico 4
QA - Qatar 4
XK - ???statistics.table.value.countryCode.XK??? 4
Totale 50.277
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.422
Ann Arbor 2.344
Singapore 2.205
Ashburn 1.928
Fairfield 1.925
Houston 1.785
Jacksonville 1.402
San Jose 1.252
Chandler 1.137
Wilmington 1.044
Hong Kong 937
Seattle 799
Hefei 769
Seoul 681
Cambridge 649
Council Bluffs 592
Warsaw 549
Princeton 523
Beijing 506
Izmir 494
Boardman 465
Columbus 429
Chicago 364
Trieste 321
Ho Chi Minh City 292
Sofia 292
Milan 290
Dublin 285
Munich 268
Zgierz 257
Santa Clara 247
Lauterbourg 246
Los Angeles 236
Dallas 223
Dearborn 222
Hanoi 212
Moscow 184
Buffalo 181
Helsinki 145
The Dalles 132
San Diego 128
New York 91
Düsseldorf 84
Frankfurt am Main 80
Redwood City 73
Phoenix 72
Verona 72
Bern 70
Mcallen 67
São Paulo 67
London 62
Guangzhou 60
Nanjing 53
Rome 51
Mestre 49
Des Moines 48
Montréal 48
Orem 47
Atlanta 42
Shanghai 42
Rio de Janeiro 41
Dakar 40
Haiphong 39
Tokyo 39
Chennai 38
Da Nang 38
Brooklyn 37
Norwalk 37
Miano 36
Kocaeli 34
Montreal 34
Kunming 33
Turku 32
Tianjin 31
Brussels 30
San Francisco 29
Denver 28
Redondo Beach 28
Amsterdam 26
Toronto 26
Casablanca 25
Bremen 23
Mexico City 22
Philadelphia 22
Zhengzhou 22
Andover 21
Can Tho 21
Charlotte 21
Jinan 21
Abidjan 20
Johannesburg 20
Nairobi 20
Naples 20
Ottawa 20
Vienna 20
Washington 20
Wuhan 20
Baghdad 19
Dhaka 19
Florence 19
Totale 31.631
Salva come PNG Salva come JPEG
Nome #
Chimica Inorganica, seconda edizione italiana condotta sulla quinta edizione inglese 700
Neutral 1,3,5-Triaza-7-phosphaadamantane-Ruthenium(II) Complexes as Precursors for the Preparation of Highly Water-Soluble Derivatives 609
Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity 401
New Insight into a Deceptively Simple Reaction: The Coordination of bpy to RuII-Carbonyl Precursors - The Central Role of thefac-[Ru(bpy)Cl(CO)3]+Intermediate and theChloride Rebound Mechanism 387
1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for thepreparation of ruthenium complexes with potential anticancer activity 378
New Cationic and Neutral Ru(II)- and Os(II)-dmso carbonyl Compounds 369
Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective 345
A noncovalently linked, dynamic fullerene porphyrin dyad. Efficient formation of long-lived charge separated states through complex dissociation. 313
Palladium complexes with simple iminopyridines as catalysts for polyketone synthesis 313
Side-to-face ruthenium porphyrin arrays. Photophysical behavior of dimeric and pentameric systems. 312
(15)N NMR spectroscopy unambiguously establishes the coordination mode of the diimine linker 2-(2'-pyridyl)pyrimidine-4-carboxylic acid (cppH) in Ru(II) complexes 309
A spectroscopic study of the reaction of NAMI, a novel ruthenium(III) anti-neoplastic complex, with bovine serum albumin 286
Rare Example of Stereoisomeric 2 + 2 Metallacycles of Porphyrins Featuring Chiral-at-Metal Octahedral Ruthenium Corners 284
New salts of anionic complexes of Ru(III) as antimetastatic and antineoplastic agents. 283
Synthesis, Molecular Structure and Chemical Behavior of Hydrogen trans-bis(Dimethylsulfoxide)Tetrachlororuthenate(III) and mer-Trichlorotris(Dimethylsulfoxide)Ruthenium(III) - the First Fully Characterized Chloride Dimethylsulfoxide Ruthenium(III) Complexes 281
Design of photoactivatable metallodrugs: Selective and rapid light-induced ligand dissociation from half-sandwich [Ru([9]aneS3)(N–N′)(py)]2+ complexes 277
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry 276
Complessi dicarbossilati del rutenio(II) e loro impiego come antitumorali 264
A categorization of metal anticancer compounds based on their mode of action. 264
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy 260
Sulfoxide ruthenium complexes: non toxic tools for the selective treatment of solid tumour metastases. 257
Antitumor action of mer-trichlorobis(dimethyl sulfoxide)aminoruthenium(III) (BBR2382) in mice bearing Lewis lung carcinoma 254
Activation of Rh6(CO)16 with 1,10-phenanthroline and substituted derivatives in the catalytic reduction of nitrobenzene to aniline with carbon monoxide and water 252
null 252
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 246
Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors 246
Synthesis and characterization of new halogen -tetramethylene sulfoxide-ruthenium(II) and ruthenium(III) complexes; crystal structure of cis-dichlorotetrakis(tetramethylene sulfoxide) ruthenium(II) and hydrogen trans-bis(tetramethylene sulfoxide)tetrachlororuthenate(III) 244
Response of MCa mammary carcinoma to cisplatin and to Na[trans-RuCl4(DMSO)(Im)]. 244
Discrete Supramolecular Assemblies of Porphyrins Mediated by Coordination Compounds 242
The rare head-to-head conformation of untethered lopsided ligands discovered in both solution and solid states of 1,5,6-trimethylbenzimidazole Re(V) and Ru(II) complexes. 241
The Insertion of Ruthenium into Porphyrins Revisited and Improved: Proof of Concept Results with a Ruthenium(II) Monocarbonyl Compound, and the Spectacular Effect of Propionic Acid 241
Solution and solid state structure of a canted, side-to-face, bis-porphyrin adduct. 240
New atropisomeric bidentate nitrogen-donor compounds as potential stereocontrollers in mild CO-styrene copolymerisation catalysed by palladium(II) salts. 240
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 240
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels 237
Water-Soluble Ruthenium(II) Carbonyls with 1,3,5-Triaza-7-phosphoadamantane 237
trans-Ru(II)dimethylsulfoxides: antineoplastic action on mouse tumors 236
Ruthenium(III) complexes as antineoplastic agents. 235
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in theLewis lung carcinoma system. 235
The synthesis of RuBr2(DMSO)3 revisited: a mixture of Li[fac-RuClnBr3-n(DMSO)3] isomers (n = 0-3) is the reaction product 235
A novel open-box shaped pentamer of vertically linked porphyrins that selectively recognizes S-bonded Me2SO complexes. 233
Activation of carbonyl clusters with 1,10-phenanthroline and related ligands: the reduction of nitrobenzene as a model reac¬tion for MX(CO)Y (M = Ru, Os, Ir) + Phen systems as catalyst precursors 232
Carbonyl derivatives of chloride dimethyl-sulfoxide ruthenium(II) complexes. Synthesis, structural characterization, and reactivity of Ru(CO)(X)(Dmso)(4-X)Cl-2 complexes (X=1-3) 232
Wavelength-Dependent Electron and Energy Transfer Pathways in a Side-to-Face Ruthenium Porphyrin / Perylene Bisimide Assembly 231
Ruthenium anticancer compounds: challenges and expectations 231
Phototoxic Activity and DNA Interactions of Water-Soluble Porphyrins and Their Rhenium(I) Conjugates 230
Tumor inhibition and effects on host survival time by rutheniumIII andrhodiumIII complexes with dimethylsulphoxide ligands. 229
Antineoplastic effects of mer-RuCl3(DMSO)2(NH3) against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4]. 229
Ruthenium-Porphyrin Conjugates with Cytotoxic and Phototoxic Antitumor Activity 229
A Functionalized Noncovalent Macrocyclic Multiporphyrin Assembly from a Dizinc(II) Bis-Porphyrin Receptor and a Free-Base Dipyridylporphyrin 227
Synthesis and Properties of Novel Fullerene Derivatives 227
Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media 225
Coordination and release of NO by ruthenium-dimethylsulfoxide complexes - implications for anti-metastases activity. 225
Antimetastatic action and toxicity on healty tissues of Na[trans-RuCl4(DMSO)Im] in the mouse. 224
Geometrical and linkage isomers of OsCl2(dmso)4: the complete picture 224
Complexed bridging ligands: oxorhenium(V) compounds with mono-coordinated pyrazine or pyrimidine as possible building-blocks for the construction of polynuclear architectures. 223
Synthesis, structural characterization and chemical behavior of new dimeric Ru(III) complexes 223
C60 in the Box. A Supramolecular C60 - Porphyrin Assembly 222
Reduction of lung metastases by Na[trans-RuCl4(DMSO)Im] is not coupled with the induction of chemical xenogenization 222
Factors that influence the antiproliferative activity of half sandwich RuII-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives. 222
Antimetastatic action and toxicity on healthy tissues ofNa[trans-RuCl4(DMSO)Im] in the mouse. 221
Antileukemic action of RuCl2(DMSO)4 isomers and prevention of brain involvement on P388 leukemia and on P388/DDP subline 221
Crystals containing conformers: a rare case in which a solid closely reflects a solution equilibrium mixture 219
Metal-mediated multi-porphyrin discrete assemblies and their photoinduced properties. 219
Complessi di Rutenio con elevata attività antitumorale 219
Ru(ii)-Peptide bioconjugates with the cppH linker (cppH = 2-(2'-pyridyl)pyrimidine-4-carboxylic acid): synthesis, structural characterization, and different stereochemical features between organic and aqueous solvents 219
Photolabile Ru Model Complexes with Chelating Diimine Ligands for Light-Triggered Drug Release 219
New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity. 218
COMPLESSI DI Ru(III) COME AGENTI ANTINEOPLASTICI 217
Structure of trans-dichlorotetrakis(dimethyl sulfoxide)rhodium(III) tetrafluoroborate 217
Synthesis and characterization of a new series of palladium(II) compounds with nitrogen-donor chelating ligands: [Pd(chel)(L)2][PF6]2 217
Chemical properties of rare platinum metal complexes having antitumor activity 216
Rhodium(III) analogues of antitumour-active ruthenium(III) compounds: the crystal structure of [ImH][trans-RhCl4(Im)2] (Im= imidazole) 216
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[{trans-RuCl4(Me2SO)}2(μ-L)] (L=ditopic, non-chelating aromatic N-ligand). A preliminary investigation 215
Efficacy of 5-FU combined to Na[trans-RuCl4(DMSO)(Im)], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline and MCa mammary carcinoma 215
The NAMI A - human ferritin system: a biophysical characterization 215
Is the aromatic fragment of piano-stool ruthenium compounds an essential feature for anticancer activity? The development of new Ru(II)-[9]aneS3 analogues. 214
Complessi trans di rutenio come agenti antineoplastici 213
Two-point self-coordination of a dizinc(ii) bis-pyridylporphyrin ruthenium complex leading selectively to a discrete molecular assembly: solution and solid state characterization 213
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties 213
Porphyrin "flying saucers": Solid state and solution structure of a novelpentameric array of axially-ligated canted porphyrins. 210
Free exchange across cells,and echistatin-sensitive membrane target for the metastasis inhibitor NAMI-A(imidazolium trans-imidazole dimethyl sulfoxide tetrachlororuthenate)ON KB Tumor cells. 210
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 210
Photo-active triads self-assembled around a pivot aluminum(III)porphyrin 209
Synthesis and characterization of novel Re(I)-Porphyrin dyad and triad for photoinduced electron-transfer 208
Electrochemistry of Sodium trans-bis(Dimethylsulphoxide)Tetrachlororuthenate(III) and mer-Trichlorotris(Dimethylsulphoxide)Ruthenium(III) - the First and Complete Electrochemical Characterization of Chlorodimethyl Sulfoxide Ruthenium(III) Complexes 206
Sistemi periodici: una proposta didattica interdisciplinare tra chimica e letteratura 206
Synthesis and Reactivity of Ru-, Os-, Rh-, and Ir-halide-sulfoxide Complexes. 205
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A 204
NMR structural characterization of the reaction product between d(GpG) and the octahedral antitumor complex trans-RuCl2(DMSO)4. 204
Novel Ru(III)-dimethyl sulfoxide catalysts for the selective oxidation of thioethers to sulfoxides with molecular oxygen 204
Carbonyl derivatives of chloride-dimethyl sulfoxide-ruthenium(III) complexes. Synthesis, crystal-structure, and reactivity of [(Dmso)(2)H][Trans-RuCl4(Dmso)(CO)] and mer, cis-RuCl3(Dmso)(2)(CO) 204
Synthesis and Characterization of Two New Classes of Ruthenium(III-Sulfoxide Complexes with Nitrogen Donor Ligands (L) - {$Na\left[\mathit{trans}-RuCl_4(R_2SO)(L)\right]$} and {$\mathit{mer,cis}-RuCl_3(R_2SO)(R_2SO)(L)$} - the crystal structure of {$Na\left[\mathit{trans}-RuCl_4(DMSO)(NH_3)\right]\cdot{}2DMSO$}, {$Na\left[\mathit{trans}-RuCl_4(DMSO)(Im)\right]\cdot{}{H_2O},{Me_2CO}$} (Im=Imidazole) and {$\mathit{mer,cis}-RuCl_3(DMSO)(DMSO)(NH_3)$} 204
Anticancer ruthenium complexes 204
Chemistry and reactivity of ruthenium(II) complexes: DNA/protein binding mode and anticancer activity are related to the complex structure 204
Half-sandwich RuIIsingle bond[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: Preparation, structural characterization and in vitro cytotoxic activity 203
Energy Transfer Pathways in Pyridylporphyrin Re(I) Adducts. 202
Mixed-ligand rhenium(V) oxo monomers with triphenylphosphine oxide and lopsided and symmetrical heterocyclic ligands. Putative intermediates in rhenium(V) oxo synthetic chemistry 202
Na[trans-RuCl4(DMSO)(Im)]*2DMSO - antimetastatic ruthenium agent 202
Synthetic Strategies and Structural Aspects of Metal-Mediated Multi-Porphyrin Assemblies 201
Totale 24.743
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.429
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.565 0 0 0 419 70 224 94 125 355 298 213 767
2022/20233.639 373 433 264 440 436 688 32 289 433 23 169 59
2023/20241.907 173 139 91 165 194 107 206 493 15 33 167 124
2024/20255.099 84 311 470 454 463 490 458 373 564 462 369 601
2025/202612.099 957 831 1.091 1.064 933 1.190 1.657 476 1.333 1.700 484 383
2026/20272.382 463 708 1.202 9 0 0 0 0 0 0 0 0
Totale 51.182